A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

• Status: Unknown status
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

New strategy to improve the outcomes in patients with HCC and acute variceal bleeding. NSBB added to endoscopic ligation may further reduce rebleeding in cirrhotic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taipei Veterans General Hospital, Taiwan
• Treatments: Propranolol

Criteria

Inclusion Criteria:

• Clinical diagnosis of HCC, endoscopically proven gastroesophageal variceal bleeding

• Aged 18 to 80

Exclusion Criteria:

• Had a terminal illness of any major organ system,such as heart failure, kidney failure, COPD